Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart PHAXIAM Therapeutics S.A.

Equities

PHXM

FR001400K4B1

End-of-day quote Euronext Paris
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
2.865 EUR -0.52% Intraday chart for PHAXIAM Therapeutics S.A. -4.34% -37.72%
Apr. 15 Phaxiam initiates trial in infective endocarditis CF
Apr. 15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PHAXIAM THERAPEUTICS S.A.
Bio Therapeutic Drugs
-0.52%-4.34%-37.72%-65.65%-95.51% 18.81M
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. Charts PHAXIAM Therapeutics S.A.
  5. Relative Strength Chart